Phreesia’s MediFind Launches AI Chatbot Chloe to Streamline Provider Matching
Event summary
- Phreesia subsidiary MediFind launched 'Chloe,' an AI-powered chatbot designed to help patients find and book healthcare providers.
- Chloe guides users through a conversational intake process, using MediFind’s database of over 2 million clinicians to provide tailored provider matches.
- The tool aims to reduce incorrect bookings and scheduling setbacks by capturing patient details upfront.
- Phreesia acquired MediFind in July 2023.
The big picture
Phreesia’s launch of Chloe underscores the growing emphasis on AI-driven personalization in healthcare navigation. As patients increasingly seek specialized care for chronic or rare conditions, tools like Chloe could reduce administrative friction—though success hinges on seamless integration with existing provider systems. Phreesia’s 2023 acquisition of MediFind positions it to leverage data analytics at scale, but the broader trend of AI-assisted healthcare discovery remains competitive.
What we're watching
- Adoption Pace
- How quickly patients and providers will integrate Chloe into their workflows, given the complexity of healthcare navigation.
- Competitive Response
- Whether existing provider directories like Zocdoc or Healthgrades will accelerate AI-driven matching features in response.
- Data Utilization
- The extent to which MediFind’s database of 2 million clinicians can sustain Chloe’s accuracy and scalability over time.
Related topics